BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35155620)

  • 1. The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis.
    Guan B; Zhao L; Ma D; Fan Y; Zhang H; Wang A; Xu H
    Front Cardiovasc Med; 2021; 8():820604. PubMed ID: 35155620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Giua R; Pedone C; Ray KK; Vallejo-Vaz AJ; Costanzo L
    Pharmacol Res; 2016 Sep; 111():163-179. PubMed ID: 27320045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis.
    Chen W; Zhang C; Zhao J; Xu X; Dang H; Xiao Q; Li Y; Hou H
    Clin Cardiol; 2021 Apr; 44(4):488-494. PubMed ID: 33704801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.
    Ariotti S; Ortega-Paz L; van Leeuwen M; Brugaletta S; Leonardi S; Akkerhuis KM; Rimoldi SF; Janssens G; Gianni U; van den Berge JC; Karagiannis A; Windecker S; Valgimigli M;
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1576-1586. PubMed ID: 29805112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of catechin on endothelial function: A systematic review and meta-analysis of randomized controlled trials.
    Shafabakhsh R; Milajerdi A; Reiner Ž; Kolahdooz F; Amirani E; Mirzaei H; Barekat M; Asemi Z
    Crit Rev Food Sci Nutr; 2020; 60(14):2369-2378. PubMed ID: 31389256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.
    Jeong HS; Hong SJ; Cho SA; Kim JH; Cho JY; Lee SH; Joo HJ; Park JH; Yu CW; Lim DS
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1646-1658. PubMed ID: 28838475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of differential effect of ticagrelor versus prasugrel maintenance dose on endothelial function in patients with stable coronary artery disease.
    Xanthopoulou I; Bei I; Bampouri T; Barampoutis N; Moulias A; Davlouros P; Alexopoulos D
    Hellenic J Cardiol; 2018; 59(6):338-343. PubMed ID: 29292242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M
    Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of major adverse cardiovascular events of
    Biswas M; Kali MSK; Biswas TK; Ibrahim B
    Platelets; 2021 Jul; 32(5):591-600. PubMed ID: 32664772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.
    Wen M; Li Y; Qu X; Zhu Y; Tian L; Shen Z; Yang X; Shi X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):430. PubMed ID: 33004000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Khan MS; Memon MM; Usman MS; Alnaimat S; Khan SU; Khan AR; Yamani N; Fugar S; Mookadam F; Krasuski RA; Doukky R
    Am J Cardiovasc Drugs; 2019 Oct; 19(5):465-476. PubMed ID: 30828769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Bariatric Surgery on Flow-Mediated Vasodilation as a Measure of Endothelial Function: A Systematic Review and Meta-Analysis.
    Jamialahmadi T; Alidadi M; Atkin SL; Kroh M; Almahmeed W; Moallem SA; Al-Rasadi K; Rodriguez JH; Santos RD; Ruscica M; Sahebkar A
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coffee consumption on arterial stiffness and endothelial function: a systematic review and meta-analysis of randomized clinical trials.
    Azad BJ; Heshmati J; Daneshzad E; Palmowski A
    Crit Rev Food Sci Nutr; 2021; 61(6):1013-1026. PubMed ID: 32292049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akkaif MA; Sha'aban A; Daud NAA; Yunusa I; Ng ML; Sk Abdul Kader MA; Noor DAM; Ibrahim B
    J Cardiovasc Dev Dis; 2021 Sep; 8(10):. PubMed ID: 34677192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor for the primary prevention of stroke in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Kong Q; Ma X; Zhao X; Chen F; Hou C
    J Thromb Thrombolysis; 2020 Nov; 50(4):942-956. PubMed ID: 32221808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Safety and Efficacy Between Clopidogrel and Ticagrelor in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Zhao X; Zhang J; Guo J; Wang J; Pan Y; Zhao X; Sang W; Yang K; Xu F; Xu F; Chen Y
    Front Pharmacol; 2021; 12():743259. PubMed ID: 34721032
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials.
    Ling H; Fu S; Xu M; Wang B; Li B; Li Y; Liu X; Zhang X; Wang Q; Li A; Liu M
    Quant Imaging Med Surg; 2024 Feb; 14(2):1451-1465. PubMed ID: 38415135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials.
    Ray A; Najmi A; Khandelwal G; Jhaj R; Sadasivam B
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):561-574. PubMed ID: 32816142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.